Hematology NewsSmoking Linked to More Genetic Havoc in MDSDecember 11, 2024Myelodysplastic SyndromeAMLASH 2024
Hematology NewsFertility Preservation in SCD: Women Have More ComplicationsDecember 11, 2024Bleeding DisordersAnemiaMixed TopicsASH 2024
Hematology NewsDoes Acalabrutinib Fit Into Frontline MCL Therapy?December 11, 2024Mantle Cell LymphomaB Cell LymphomaASH 2024
Hematology NewsPOLARIX: Extended Results Confirm Standard of Care for DLBCLDecember 11, 2024DLBCLNon-Hodgkin LymphomaASH 2024
Hematology NewsRilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat Immune ThrombocytopeniaDecember 10, 2024Bleeding DisordersThrombosisASH 2024
Hematology NewsEpcore NHL-1 Update: Treatment Effective Before CAR TDecember 10, 2024DLBCLB Cell LymphomaNon-Hodgkin LymphomaCellular TherapyASH 2024
Hematology NewsWith Chemo, Blinatumomab Boosts DFS in Pediatric B-ALLDecember 9, 2024ALLPediatricsASH 2024
Hematology NewsHigh-Fiber Diet Linked to Improved Stem Cell Transplant, GvHD OutcomesDecember 9, 2024TransplantPatient & Survivor CareALLCLLNon-Hodgkin LymphomaMyelodysplastic SyndromeMixed Topics
Hematology News24-Hour Urine Testing in Multiple Myeloma: Time to Stop?December 9, 2024Multiple MyelomaPatient & Survivor CareASH 2024
Hematology NewsIVIG Prophylaxis in Multiple Myeloma Cuts Infections, Boosts SurvivalDecember 9, 2024Multiple MyelomaASH 2024
Hematology NewsLBCL: Bispecific Antibodies Fare Less Well in Real-World AnalysisDecember 9, 2024DLBCLB Cell LymphomaNon-Hodgkin LymphomaPatient & Survivor CareASH 2024
Hematology NewsASH 2024: New Leukemia Txs, Fewer Blood Clots With GLP-1 RxsDecember 9, 2024ALLCLLBleeding DisordersThrombosis
Hematology NewsASH 2024 Myeloma Studies: My Top 10 PicksNovember 22, 2024Multiple MyelomaCellular TherapyPatient & Survivor Care
Oncology PracticeCancer Mortality Not Higher for Patients With Autoimmune Disease on Checkpoint InhibitorsNovember 21, 2024ImmunotherapyGastroenterology
